Material Event (Form 8-K)

Item 8.01 Other Events.

On September 20, 2025, the Board of Directors of Intelligent Bio Solutions Inc. (the "Company") approved extending the termination date of the Company's outstanding Series H-1 Common Stock Purchase Warrants (the "Series H-1 Warrants") from 5:00 p.m. (New York City time) on September 27, 2025, to 5:00 p.m. (New York City time) on March 27, 2026. The exercise prices and other terms of the Series H-1 Warrants remain unchanged. There are currently outstanding Series H-1 Warrants to purchase an aggregate of 1,034,213 shares of the Company's common stock held by six warrant holders, each of whom consented to extending the termination date. The Company did not receive any consideration in connection with extending the termination date of the Series H-1 Warrants. Other than the consent of the warrant holders to the extension, there are no agreements or understandings between the Company and the warrant holders related to extending the termination date of the Series H-1 Warrants.

The foregoing description of the amended Series H-1 Warrants is qualified in its entirety by reference to the full text of the Series H-1 Warrant, a copy of which is attached to this Current Report on Form 8-K as Exhibit 4.1.